1020857-40-2

Upstream product

• 1020857-03-7 (2H,2H,4H,4H,-3,6,9,12-tetraoxaperfluorotridecanoic acid)N-methylamide 
• 1020857-02-6 2H,2H,4H,4H,-3,6,9,12-tetraoxaperfluorotridecanoic acid 
• 147492-57-7 2-(2-(2-(trifluoromethoxy)tetrafluoroethoxy)tetrafluoroethoxy)-2,2-difluoro-1-ethanol 
• 1020857-04-8 N-methyl-(1H,1H,2H,2H,4H,4H,-3,6,9,12-tetraoxaperfluorotridecyl)amine 
• 13574-13-5 Boc-Glu(OBzl)-OH 

Downstream Products

• 1020857-41-3 L-glutamic acid 5-benzyl ester 1-[(1H,1H,2H,2H,4H,4H,-3,6,9,12-tetraoxaperfluorotridecyl)methyl]amide 
• 1020857-42-4 L-glutamic acid 5-benzyl ester N-(2-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}acetyl)-1-[(1H,1H,2H,2H,4H,4H,-3,6,9,12-tetraoxaperfluorotridecyl)methyl]amide 

Relevant academic research and scientific papers

METAL CHELATES HAVING A PERFLUORINATED PEG RADICAL, PROCESSES FOR THEIR PREPARATION, AND THEIR USE

The invention relates to the subjects characterized in the patent claims, namely metal chelates having a perfluorinated PEG radical, processes for their preparation, and their use, processes for their preparation and their use in NMR and X-ray diagnosis, radiodiagnosis and radiotherapy, and in MRT lymphography.